Evidence map›Paper›PMID 41972259›Full record

ArticlePediatric dermatology

Novel Combination of UVA-1 Phototherapy With Topical Tofacitinib for Treating Eosinophilic Fasciitis With Morphea: Case Report.

Daphne M Cheung, Ye-Jean Park, Nadia Luca, Frankie Fraulin, Marie-Anne Brundler, Michele Ramien

Abstract readCase Reports
In one paragraph

Article in Pediatric dermatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Daphne M CheungDepartment of Paediatrics, Alberta Children's Hospital and University of Calgary, Calgary, Alberta, Canada.ORCID https://orcid.org/0009-0003-2607-5588
Ye-Jean ParkTemerty School of Medicine, University of Toronto, Toronto, Ontario, Canada.
Nadia LucaSection of Paediatric Rheumatology, Department of Paediatrics, Alberta Children's Hospital and University of Calgary, Calgary, Alberta, Canada.
Frankie FraulinDepartment of Surgery, Alberta Children's Hospital and University of Calgary, Calgary, Alberta, Canada.
Marie-Anne BrundlerDepartment of Pathology and Laboratory Medicine, Alberta Children's Hospital and University of Calgary, Calgary, Alberta, Canada.
Michele RamienDepartment of Paediatrics, Alberta Children's Hospital and University of Calgary, Calgary, Alberta, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eosinophilic fasciitis (EF) and morphea are rare sclerosing connective tissue disorders, and there remains debate about whether these entities are pathologically distinct or related. This case report describes the successful treatment of an adolescent patient who developed progressive morphea plaques while being treated with systemic corticosteroids, intravenous immunoglobulin, and methotrexate for EF. A novel combination of topical tofacitinib, a Janus kinase (JAK) inhibitor, and UVA-1 phototherapy induced clinical remission and was well tolerated, warranting further investigation into such combination therapy.

Indexed as

EosinophiliaFasciitisPiperidinesPyrimidinesPyrrolesScleroderma, LocalizedUltraviolet TherapyAdolescentCombined Modality TherapyHumansProtein Kinase InhibitorsPiperidinesProtein Kinase InhibitorsPyrimidinesPyrrolestofacitinibantirheumatic agents/therapeutic useeosinophiliafasciitisglucocorticoids/therapeutic use*humansimmunosuppressive agents/therapeutic use*joint diseases/etiologymethotrexate/therapeutic use*skin diseases/etiology

Identifiers

PMID41972259
PMCPMC13423113

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.